(TOKE) Cambria Cannabis - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US1320618218

Cannabis, Companies, ETF, Fund, Swaps

Description: TOKE Cambria Cannabis

The Cambria Cannabis ETF (BATS:TOKE) is an actively managed exchange-traded fund that focuses on investing in cannabis-related companies, utilizing total return swaps to gain exposure to the sector. This investment strategy allows the fund to capitalize on the growth potential of the cannabis industry.

As an ETF categorized under the Miscellaneous Sector, TOKE provides a unique investment opportunity for those looking to tap into the cannabis market. With its USA origin, the fund is subject to US regulatory environments, which can impact its investment choices and overall performance.

Analyzing the funds technical data, we observe a current price of $4.71, sitting exactly on its 20-day Simple Moving Average (SMA20), indicating a potential balance between bullish and bearish forces. The 50-day SMA is at $4.49, suggesting a short-term uptrend, while the 200-day SMA at $5.17 indicates a longer-term downtrend. The Average True Range (ATR) of 0.16, translating to a 3.39% daily volatility, suggests moderate price fluctuations. Given these indicators, a potential trading range between the 52-week high of $6.27 and low of $3.88 is established.

From a fundamental perspective, the funds Assets Under Management (AUM) stand at $12.05M USD, a relatively modest size that could impact liquidity and potentially amplify the effects of significant trades.

Combining technical and fundamental insights, a forecast for TOKE can be derived. Given the current technical indicators and the relatively small AUM, the fund may face challenges in maintaining a stable uptrend. However, if the cannabis sector continues to attract investment and grow, TOKE could potentially move towards its 52-week high. Conversely, any negative developments in the sector could drive the price down towards its 52-week low. A likely short-term scenario involves trading within the established range, with potential breakout or breakdown depending on broader market sentiment towards cannabis stocks.

Based on the analysis, a potential trading strategy could involve closely monitoring the funds price action relative to its SMAs and ATR, alongside keeping abreast of developments in the cannabis industry that could impact TOKEs performance. A break above the 200-day SMA could signal a longer-term uptrend, while a drop below the 52-week low could indicate further downside.

Additional Sources for TOKE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

TOKE ETF Overview

Market Cap in USD 12m
Category Miscellaneous Sector
TER 0.42%
IPO / Inception 2019-07-25

TOKE ETF Ratings

Growth Rating -73.6
Fundamental -
Dividend Rating 20.4
Rel. Strength -26.1
Analysts -
Fair Price Momentum 3.72 USD
Fair Price DCF -

TOKE Dividends

Dividend Yield 12m 4.90%
Yield on Cost 5y 2.26%
Annual Growth 5y -11.69%
Payout Consistency 85.7%
Payout Ratio %

TOKE Growth Ratios

Growth Correlation 3m 18.7%
Growth Correlation 12m -88.1%
Growth Correlation 5y -89.6%
CAGR 5y -15.19%
CAGR/Max DD 5y -0.18
Sharpe Ratio 12m -0.88
Alpha -24.86
Beta 0.471
Volatility 23.92%
Current Volume 1.5k
Average Volume 20d 5.7k
What is the price of TOKE shares?
As of July 06, 2025, the stock is trading at USD 4.58 with a total of 1,500 shares traded.
Over the past week, the price has changed by +3.18%, over one month by +0.40%, over three months by +13.46% and over the past year by -15.58%.
Is Cambria Cannabis a good stock to buy?
No, based on ValueRay´s Analyses, Cambria Cannabis (BATS:TOKE) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -73.57 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TOKE is around 3.72 USD . This means that TOKE is currently overvalued and has a potential downside of -18.78%.
Is TOKE a buy, sell or hold?
Cambria Cannabis has no consensus analysts rating.
What are the forecasts for TOKE share price target?
According to our own proprietary Forecast Model, TOKE Cambria Cannabis will be worth about 4.2 in July 2026. The stock is currently trading at 4.58. This means that the stock has a potential downside of -8.95%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 4.2 -9%